Concepedia

Mary Taglienti

MT

Statistics

Publications

14

Citations

915

H-Index

14

Active since

2002

Affiliations

Harvard University(Current)

Boston Children's Hospital

Harvard Stem Cell Institute

Brigham and Women's Hospital

Massachusetts Institute of Technology

Mary Taglienti is an author at Harvard University specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2002–2020

14

Publications

14

Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development

Sunny Hartwig, Jacqueline Ho, Priyanka Pandey et al. · Development · 2010 · 131 citations · Full text

Genome-Wide Analysis of Wilms’ Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms

Martin Kann, Sandrine Ettou, Youngsook L. Jung et al. · Journal of the American Society of Nephrology · 2015 · 117 citations · Full text

, , +15

Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa

Xiaobo Gao, Xing Chen, Mary Taglienti et al. · Development · 2005 · 112 citations

, , +17

Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis

Yingjie Liu, Nibedita Chattopadhyay, Shan Qin et al. · Development · 2009 · 85 citations · Full text

Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease

Shan Qin, Mary Taglienti, Surya M. Nauli et al. · Journal of Clinical Investigation · 2010 · 73 citations · Full text

, , +19

1–5 of 14